Proton Pump Inhibitors: Your Questions Answered

How Do Proton Pump Inhibitors Work?

PPIs are the most commonly prescribed medicines for acid-related disorders in the UK. They significantly reduce the amount of acid the stomach produces — but patients often have questions about how they differ, whether they all cause the same side effects, and what to do if one doesn’t suit them.

Your stomach lining contains millions of specialised cells called parietal cells, whose job is to secrete hydrochloric acid. Inside these cells are protein pumps — known as proton pumps or H⁺/K⁺-ATPase enzymes — that are responsible for the final step in acid secretion. PPIs work by entering the parietal cell, being activated by the acidic environment, and then irreversibly binding to and disabling these pumps.

The irreversible binding is key: the drug stays active for far longer than it circulates in the bloodstream. A single dose suppresses acid for 24–48 hours, even though the drug itself is cleared within a few hours. Acid production only fully resumes once the parietal cells regenerate their proton pumps — which takes around two days.

What Are the Differences Between Proton Pump Inhibitors?

On paper, all PPIs are remarkably similar. They share almost the same chemical structure, work through exactly the same mechanism, and produce broadly equivalent clinical outcomes when used at equivalent doses. The reason head-to-head trials comparing PPIs are relatively sparse is telling: clinicians haven’t found enough meaningful differences to make large-scale comparative studies worthwhile.

That said, there are clinically relevant differences in specific situations:

• Drug interaction profile: Omeprazole and esomeprazole interact more with the CYP2C19 enzyme pathway than lansoprazole, pantoprazole, or rabeprazole. This is relevant when co-prescribing with clopidogrel, some antiepileptics, or certain antidepressants.
• Potency at higher doses: Esomeprazole (the S-isomer of omeprazole) may offer marginally superior acid suppression at higher doses, though this difference is rarely clinically significant.
• Tablet formulation: Lansoprazole is available as an orally disintegrating tablet (Zoton FasTab), which is useful for patients who have difficulty swallowing capsules. Rabeprazole and pantoprazole have smaller tablet sizes.
• Cost: Generic omeprazole and lansoprazole are both very low cost. Esomeprazole as Nexium (branded) is considerably more expensive, though generic esomeprazole is also available.

Individual PPI Profiles

Five PPIs are currently licensed for use in the UK. Here is a brief clinical profile of each:

For a full head-to-head comparison of the three most commonly prescribed agents, see our omeprazole vs lansoprazole vs esomeprazole comparison.

What to Expect When Starting a PPI

Many people notice an improvement in heartburn and acid reflux symptoms within two to three days of starting a PPI. However, it is important to understand that PPIs work best when taken consistently and correctly — their acid-suppressing effect builds up over several days of regular use, and they reach peak effectiveness after 3–5 days of daily dosing.

• Take your PPI at the same time each day — ideally 30–60 minutes before your first meal for maximum effect
• Swallow capsules or tablets whole — do not crush or chew unless the formulation is specifically designed for this (e.g. dispersible tablets)
• Continue for the full course prescribed — stopping early may result in incomplete healing
• Do not take with antacids unless advised to do so — allow at least two hours between them

Side Effect Profiles

PPIs are generally very well tolerated, and serious side effects are uncommon with short-term use. Because all PPIs work by the same mechanism, their side effect profiles are broadly similar — though individual patients may tolerate some better than others.

Common side effects (all PPIs)

• Headache — the most commonly reported side effect across the class
• Diarrhoea or constipation
• Nausea or abdominal pain
• Bloating or flatulence
• Skin rash (usually mild)

These effects are typically mild and resolve on their own. They affect roughly 1–2% of users. If they are troublesome, switching to a different PPI may help, even though the mechanism of action is the same.

Less common but important side effects

• Hypomagnesaemia (low magnesium) — associated with long-term use; may cause muscle cramps, fatigue, or cardiac arrhythmias
• Vitamin B12 deficiency — with long-term continuous use
• Increased susceptibility to gastrointestinal infections (e.g. Clostridium difficile)
• Modest increase in fracture risk — particularly in older adults

Can You Switch If You Get Side Effects?

Yes — and this is a well-established clinical practice. Evidence from clinical trials and real-world prescribing shows that patients who experience side effects on one PPI do not always experience the same side effects when switched to a different agent. Although the class effect in terms of efficacy is assumed, individual patient responses to different PPIs can vary meaningfully.

If you are experiencing side effects on your current PPI, speak to your prescriber. Switching to a different PPI is a straightforward process that does not require a gap in treatment. The prescriber will consider which alternative is most appropriate based on your medical history and any concurrent medicines.

The one exception where caution is needed is a true allergic reaction. If you have experienced anaphylaxis or significant hypersensitivity to a PPI, inform your prescriber before any switch is made — cross-reactivity between PPIs is possible, though not certain.

Stopping PPIs Safely

PPIs should not be stopped abruptly after long-term use. When PPIs are discontinued suddenly, the stomach can temporarily produce more acid than it did before treatment — a phenomenon known as rebound acid hypersecretion. This can cause a temporary return of symptoms and may lead patients to believe their reflux has worsened, when in fact it is a short-term physiological response to cessation.

To minimise rebound effects, NICE recommends a gradual step-down approach:

• Reduce to the lowest effective dose before stopping
• Switch to on-demand (as-needed) dosing before stopping completely
• Consider a short course of an H2 receptor antagonist during the transition period
• Maintain lifestyle modifications throughout to reduce the likelihood of relapse

Which PPIs Are Available Over the Counter?

Low-dose versions of three PPIs are available without a prescription from UK pharmacies for short-term management of heartburn and acid reflux in adults:

• Omeprazole 10mg — most commonly available OTC brand
• Lansoprazole 15mg — available OTC as Zoton FasTab
• Esomeprazole 20mg — available OTC in some pharmacies

OTC PPIs are intended for short-term use — typically a maximum of four weeks. If symptoms persist beyond this, or if you require a higher dose, a prescription from a qualified prescriber is needed. Access Doctor’s regulated prescribers can assess your symptoms online and issue a prescription where appropriate.